Company:  ADAMIS PHARMACEUTICALS CO ... (ADMP)
Form Type:  8-K
Filing Date:  2/21/2020 
CIK:  0000887247 
Address:  11682 EL CAMINO REAL
SUITE 300
 
City, State, Zip:  SAN DIEGO, California 92130 
Telephone:  (858) 997-2400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.53  
Change: 
0.0634 (13.62%)  
Trade Time: 
May 22  
Market Cap: 
$39.00M
Trade ADMP now with 

© 2020  
Description of Business
Adamis Pharmaceuticals Corporation ("we," "us," "our," "Adamis" or the "company") is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease, allergy and opioid overdose. Our products and product candidates in the allergy, respiratory, and opioid overdose markets include: SYMJEPI(TM) (epinephrine) Injection 0.3mg, which was approved by the U.S.
Register and access this filing in:     
  FORM 8-K
    SECTION 1 BUSINESS AND OPERATIONS
      Item 1.01. Entry into Material Definitive Agreement
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.02. Unregistered Sales of Equity Securities
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 4.1
  EXHIBIT 5.1
  EXHIBIT 10.1
  EXHIBIT 10.2
  EXHIBIT 99.1
  EXHIBIT 99.2